Glucagon-like peptide-1 analog

Overview
Glucagon-like peptide-1 analogs are a new class of drug for treatment of type 2 diabetes. One of their advantages is that they have a lower risk of causing hypoglycemia.

Licenced:

 * exenatide (2005)

Under investigation:

 * albiglutide
 * taspoglutide